CLDX
Celldex Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +9.1% ·
aandelenstroom +4.1% ·
netto nieuwe posities +8.3%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 87 | +8 | 50.70M | $1.89B | +11 | −3 |
| Q1 2026 | 82 | +10 | 42.54M | $1.35B | +12 | −2 |
| Q4 2025 | 72 | 0 | 42.78M | $1.16B | — | — |
| Q3 2025 | 17 | 0 | 35.45M | $917.00M | — | — |
| Q2 2025 | 14 | 0 | 33.46M | $680.97M | — | — |
| Q1 2025 | 11 | -1 | 21.24M | $385.48M | — | −1 |
| Q4 2024 | 12 | +1 | 21.78M | $550.46M | +2 | −1 |
| Q3 2024 | 10 | -1 | 17.69M | $601.30M | — | −1 |
| Q2 2024 | 11 | — | 17.48M | $646.94M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 8.98M | -2.9% | $226.82M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | Wellington Management ✦ | 8.98M | -2.9% | $226.82M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | Wellington Management ✦ | 8.98M | -2.9% | $226.82M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Wellington Management ✦ | 8.98M | -2.9% | $226.82M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | Wellington Management ✦ | 8.98M | -2.9% | $226.82M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Wellington Management ✦ | 8.98M | -2.9% | $226.82M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 8.98M | -2.9% | $226.82M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 3.56M | +23.5% | $89.89M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 3.56M | +23.5% | $89.89M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | State Street Global Advisors ✦ (passief) | 3.23M | — | $81.75M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 2.52M | +60.4% | $63.58M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passief) | 1.53M | -0.4% | $38.80M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passief) | 1.53M | -0.4% | $38.80M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 708.09K | -16.4% | $17.89M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 708.09K | -16.4% | $17.89M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 518.34K | -37.2% | $13.10M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 518.34K | -37.2% | $13.10M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 452.50K | +20.9% | $11.43M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 136.59K | Nieuw | $3.45M | 0.0% | New | 1 | SEC ↗ |
| 20 | Millennium Management ✦ | 93.60K | -13.4% | $2.37M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 33.02K | Nieuw | $834,542 | 0.0% | New | 1 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 21.72K | -14.3% | $548,965 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 21.72K | -14.3% | $548,965 | 0.0% | ▼ Trim | 3 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Renaissance Technologies | $3.45M | 0.0% |
| Two Sigma Investments | $834,542 | 0.0% |
Verlaten
| Marshall Wace | $9.41M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 227 houders, 72.32M aandelen, $2.21B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.